Phable, a HealthTech platform for chronic disease management has raised $12 million in Series A funding round led by Manipal Hospitals, a multi-specialty healthcare provider. Existing investor and global VC fund SOSV also participated in this round. Additionally, existing investors, Fresco Capital and Social Starts also participating in the round via secondary shares. The healthtech startup had earlier raised.

A Pre-Series A round of funding from SOSV, Fresco Capital, Social Starts, Inflection Point Ventures, LetsVenture, and Betatron Venture Group.

Founded in 2018, Phable aims at helping patients mange chronic diseases through its platform. Founded by Sumit Sinha and Mukesh Bansal the Bangalore based startup aims at making healthcare personalized, predictive and preventative. It currently has over 5000 doctors and 200,000 patients on its platform.

Mukesh Bansal and Sumit Sinha, Co-Founders, Phable said, “Phable is laser-focused on its disease management platform and a significant portion of this funding will be deployed towards technology and IP creation. In addition, Phable aims to accelerate its expansion across multiple Indian cities and ramp up growth in its existing ecosystem of doctors and patients.”

speaking about the investment Dr Ranjan Pai, Chairman, Manipal Education and Medical Group (MEMG), said, “The growing burden of chronic diseases in India is exacerbated by issues around compliance of patients with the treatment regime – including medication, lifestyle changes and periodic follow-ups. Phable would help to fill that gap and would enhance the quality of life for many patients,” added.

William Bao Bean, General Partner, SOSV, added, “Phable started with an uncompromising vision of connected healthcare, reimagined through leading-edge technology, and has been unrelenting in their efforts since day one. It's been our privilege to work with the team through our accelerator MOX and to further support Phable as they go on to better millions of lives in India.”